| The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates KK Ariën, A Abraha, ME Quinones-Mateu, L Kestens, G Vanham, EJ Arts Journal of virology 79 (14), 8979-8990, 2005 | 293 | 2005 |
| Is HIV-1 evolving to a less virulent form in humans? KK Ariën, G Vanham, EJ Arts Nature Reviews Microbiology 5 (2), 141-151, 2007 | 282 | 2007 |
| Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium I De Baetselier, C Van Dijck, C Kenyon, J Coppens, J Michiels, T de Block, ... Nature medicine 28 (11), 2288-2292, 2022 | 261 | 2022 |
| Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay J Mariën, A Ceulemans, J Michiels, L Heyndrickx, K Kerkhof, N Foque, ... Journal of virological methods 288, 114025, 2021 | 119 | 2021 |
| The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness HF Njai, Y Gali, G Vanham, C Clybergh, W Jennes, N Vidal, C Butel, ... Retrovirology 3, 1-11, 2006 | 110 | 2006 |
| Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine J das Neves, J Michiels, KK Ariën, G Vanham, M Amiji, MF Bahia, ... Pharmaceutical research 29, 1468-1484, 2012 | 103 | 2012 |
| Cross-sectional analysis of selected genital tract immunological markers and molecular vaginal microbiota in sub-Saharan African women, with relevance to HIV risk and prevention JK Kyongo, T Crucitti, J Menten, L Hardy, P Cools, J Michiels, ... Clinical and Vaccine Immunology 22 (5), 526-538, 2015 | 102 | 2015 |
| Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time KK Ariën, RM Troyer, Y Gali, RL Colebunders, EJ Arts, G Vanham Aids 19 (15), 1555-1564, 2005 | 101 | 2005 |
| In Vitro and Ex Vivo Evaluation of Polymeric Nanoparticles for Vaginal and Rectal Delivery of the Anti-HIV Drug Dapivirine J das Neves, F Araujo, F Andrade, J Michiels, KK Ariën, G Vanham, ... Molecular pharmaceutics 10 (7), 2793-2807, 2013 | 97 | 2013 |
| Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women JK Kyongo, V Jespers, O Goovaerts, J Michiels, J Menten, RN Fichorova, ... Public Library of Science 7 (8), e43951, 2012 | 95 | 2012 |
| The HIV-1 transmission bottleneck SM Kariuki, P Selhorst, KK Ariën, JR Dorfman Retrovirology 14, 1-19, 2017 | 91 | 2017 |
| In Vitro Evaluation of Viability, Integrity, and Inflammation in Genital Epithelia upon Exposure to Pharmaceutical Excipients and Candidate Microbicides Y Gali, O Delezay, J Brouwers, N Addad, P Augustijns, T Bourlet, ... Antimicrobial agents and chemotherapy 54 (12), 5105-5114, 2010 | 90 | 2010 |
| Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment M Peeters, L Verbruggen, L Teuwen, G Vanhoutte, SV Kerckhove, ... ESMO open 6 (5), 100274, 2021 | 87 | 2021 |
| Symptomatic SARS-CoV-2 re-infection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response P Selhorst, S Van Ierssel, J Michiels, J Mariën, K Bartholomeeusen, ... MedRxiv, 2020.11. 05.20225052, 2020 | 86 | 2020 |
| HIV Nef: role in pathogenesis and viral fitness KK Ariën, B Verhasselt Current HIV research 6 (3), 200-208, 2008 | 82 | 2008 |
| Persistence of IgG response to SARS-CoV-2 E Duysburgh, L Mortgat, C Barbezange, K Dierick, N Fischer, ... The Lancet Infectious Diseases 21 (2), 163-164, 2021 | 81 | 2021 |
| Zika virus in semen: a prospective cohort study of symptomatic travellers returning to Belgium R Huits, B De Smet, KK Ariën, M Van Esbroeck, E Bottieau, L Cnops Bulletin of the World Health Organization 95 (12), 802, 2017 | 76 | 2017 |
| Chikungunya fever K Bartholomeeusen, M Daniel, DA LaBeaud, P Gasque, RW Peeling, ... Nature Reviews Disease Primers 9 (1), 17, 2023 | 71 | 2023 |
| Challenges in interpreting SARS-CoV-2 serological results in African countries AN Ndaye, A Hoxha, J Madinga, J Mariën, M Peeters, FH Leendertz, ... The Lancet Global Health 9 (5), e588-e589, 2021 | 66 | 2021 |
| HIV sexual transmission and microbicides KK Ariën, V Jespers, G Vanham Reviews in medical virology 21 (2), 110-133, 2011 | 65 | 2011 |
Joachim BrouwersKU Leuven在 pharm.kuleuven.be 的电子邮件经过验证
